FDA Adverse Event Injury Summary report: N

FARAPULSE CATHETER

MDR report key: 24114487 · Received January 20, 2026

Report

Report Number
MW5182407
Event Type
Injury
Date Received
January 20, 2026
Date of Event
December 5, 2025
Report Date
January 13, 2026
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
QZI
Adverse Event
Yes
Report Source
Voluntary report
Reporter Occupation
UNKNOWN
Health Professional
*

Narratives

Description of Event or Problem · 0

PLEASE BE ADVISED THAT WHILE INVESTIGATING AN EVENT INVOLVING ONE OF OUR PRODUCTS, (B)(6) NOTED A POTENTIAL ADVERSE EVENT REGARDING A NON-(B)(6), INC PRODUCT. SITUATION: VENTRICULAR FIBRILLATION (VF) OCCURRED. TIMING - IMMEDIATELY AFTER PULSED FIELD ABLATION (PFA) WAS PERFORMED NEAR THE BOTTOM OF THE RIGHT INFERIOR PULMONARY VEIN WITH FARAPULSE. HOW TO COMPLETE THE PROCEDURE - VF WAS STOPPED BY PERFORMING EXTERNAL DIRECT CURRENT (DC) CARDIOVERSION. THE PFA WAS THEN COMPLETED, A POST-MAP WAS CREATED, AND THE PROCEDURE WAS COMPLETED WITHOUT ANY ISSUES. DESCRIPTION OF ADVERSE EVENT: VENTRICULAR FIBRILLATION. PROGRESS: DURING THE PROCEDURE, EXTERNAL DC CARDIOVERSION WAS PERFORMED, AND THE PROCEDURE WAS COMPLETED WITHOUT ANY ISSUES. PHYSICIAN'S JUDGMENT ON HEALTH HAZARD: NON-SERIOUS (MODERATE/MINOR). EXTENDED HOSPITALIZATION: NO. CAUSAL RELATIONSHIP WITH THE PRODUCT: UNKNOWN. WERE ANY ABNORMALITIES OBSERVED PRIOR TO USE OF THE PRODUCT? NONE. WERE ANY ABNORMALITIES OBSERVED DURING USE OF THE PRODUCT? NONE. THE COMPLAINT PRODUCT(S) WILL NOT BE RETURNED FOR ANALYSIS. THIS REPORT REFLECTS INFORMATION RECEIVED BY FDA IN THE FORM OF A NOTIFICATION PER 803.22 (B)(2).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
177920 FARAPULSE CATHETER PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH QZI BOSTON SCIENTIFIC CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown